NTRS
35
10
BIIB
36
8
KEY
24
2
DOV
48
2
MDLZ
28
2
WAT
55
11
BXP
39
5
FE
34
4
DE
49
3
MET
58
2
BAX
38
2
TMO
52
8
NSC
33
6
EXPE
83
8
PH
60
5
RL
73
5
CAT
47
3
AMG
33
-11
UHS
50
4
AON
25
4
NTRS
35
10
BIIB
36
8
KEY
24
2
DOV
48
2
MDLZ
28
2
WAT
55
11
BXP
39
5
FE
34
4
DE
49
3
MET
58
2
BAX
38
2
TMO
52
8
NSC
33
6
EXPE
83
8
PH
60
5
RL
73
5
CAT
47
3
AMG
33
-11
UHS
50
4
AON
25
4
Financhill
Back

Roche Holding AG Quote, Financials, Valuation and Earnings

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6

RHHVF
Roche Holding AG

Last Price:
$275.00
Seasonality Move:
0.11%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Roche Holding AG Price Quote

$275.00

Roche Holding AG Key Stats

Sell
6
Roche Holding AG (RHHVF) is a Sell
Day range:
$272.72 - $279.19
52-week range:
$233.12 - $340.88
Dividend yield:
3.97%
P/E ratio:
17.26
P/S ratio:
3.26
P/B ratio:
6.81%
Volume:
1.2K
Avg. volume:
5K
1-year change:
-3.17%
Market cap:
$219.1B
Revenue:
$67.3B
EPS:
$14.76

How Much Does Roche Holding AG Make?

Data Unavailable

Is Roche Holding AG Growing As A Company?

Data Unavailable

Roche Holding AG Stock Price Performance

What Is Roche Holding AG 52-Week High & Low?

Roche Holding AG Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Roche Holding AG?

Data Unavailable

Is Roche Holding AG Cash Flow Positive?

Data Unavailable

Roche Holding AG Return On Invested Capital

Data Unavailable

Roche Holding AG Earnings Date & Stock Price

Roche Holding AG Competitors

  • Who Are Roche Holding AG's Competitors?
    Below is a list of companies who compete with Roche Holding AG or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • NLS Pharmaceutics Ltd (NLSP)

Roche Holding AG Dividend Yield

Data Unavailable

Roche Holding AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 1.49%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable